Evotec SE (EVO)
Evotec SE operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.
$1.91-0.01%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-52.5%
The outlook
Evotec SE currently reads as bearish based on below its 50- & 200-day averages, 1% of the way from its 52-week low to high, avg target +101% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range1% of the way from its 52-week low to high
Price targetAvg target +101% vs current price
Analyst price target
~12-month · 4 analysts$3.83average target+100.7% vs now
Now $1.91
Low $2.02High $6.86
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$678.8M
52-wk high
$4.27
52-wk low
$1.90
50-day avg
$2.59
200-day avg
$3.06
Trailing P/E
—